Alefacept is a genetically modified immunosuppressive drug prescribed for treating moderate to severe chronic plaque psoriasis in adult patients who are candidates for phototherapy or systemic therapy.
This medication is a kinase inhibitor, prescribed for kidney cancer, pancreatic cancer, brain tumor(astrocytoma), hormone-receptor–positive breast cancer in postmenopausal women and prevents organ rejection in kidney therapy. It prevents the growth of cancer cells.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer